|4Feb 26, 5:34 PM ET

Arora Puneet S. 4

4 · Skye Bioscience, Inc. · Filed Feb 26, 2025

Insider Transaction Report

Form 4
Period: 2025-02-24
Arora Puneet S.
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-24+38,00038,000 total
    Exercise: $2.89Exp: 2035-02-25Common Stock (38,000 underlying)
Footnotes (1)
  • [F1]The stock option vests 25% on the one year anniversary of February 21, 2025 and 1/48th monthly thereafter.

Documents

1 file
  • 4
    wk-form4_1740609251.xmlPrimary

    FORM 4